Advanced Parkinson’s disease treatment eligibility in France: an epidemiological study (EPIPARK)

26/09/2017
01/04/2024
EU PAS number:
EUPAS20918
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

11262-synopsis_Redacted

English (131.75 KB - PDF) View document
Updated protocol

EPIPARK_Protocol_v1.0_Redacted

First published: 22/02/2024
English (1.3 MB - PDF) View document
Study results
Study results

EPIPARK_CSR Abstract_final

English (116.72 KB - PDF) View document
Study report
Other information